0.8800 USD
+0.1276
16.96%
At close Dec 20, 4:00 PM EST
After hours
0.8200
-0.0600
6.82%
1 day
16.96%
5 days
6.02%
1 month
44.55%
3 months
39.24%
6 months
-16.19%
Year to date
-46.67%
1 year
-41.33%
5 years
-82.78%
10 years
-93.62%
 

About: 111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Employees: 1,520

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

175% more call options, than puts

Call options by funds: $11K | Put options by funds: $4K

1.81% less ownership

Funds ownership: 2.13% [Q2] → 0.32% (-1.81%) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

40% less funds holding

Funds holding: 15 [Q2] → 9 (-6) [Q3]

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

90% less capital invested

Capital invested by funds: $2.31M [Q2] → $242K (-$2.06M) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for YI.

Financial journalist opinion

Based on 3 articles about YI published over the past 30 days

Neutral
Seeking Alpha
3 weeks ago
111, Inc. (YI) Q3 2024 Earnings Call Transcript
111, Inc. (NASDAQ:YI ) Q3 2024 Results Conference Call November 27, 2024 7:30 AM ET Company Participants Dr. Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer Haihui Wang - Chief Operating Officer Conference Call Participants Jessie Lu - HSBC Robert Sassoon - Water Tower Research Operator Hello, everyone, and thank you for joining 111's Conference Call today. On the call today from the Company are Dr. Gang Yu, Co-Founder and Executive Chairman; Mr.
111, Inc. (YI) Q3 2024 Earnings Call Transcript
Neutral
PRNewsWire
3 weeks ago
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Maintained Operational Profitability for the Third Consecutive Quarter Operating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoY Held Positive Operating Cash Flow for Three Consecutive Quarters SHANGHAI , Nov. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Net revenues were RMB3.6 billion (US$513.1 million), remaining relatively flat compared to the same quarter last year.
111, Inc. Announces Third Quarter 2024 Unaudited Financial Results
Neutral
PRNewsWire
4 weeks ago
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
SHANGHAI , Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Friday, December 6, 2024 at 11:00 a.m. ET. Mr. Junling Liu, Co-Founder, Chairman, and Chief Executive Officer of 111, will discuss the Company's Q3 2024 earnings (to be reported on Wednesday, November 27, 2024), along with challenges, opportunities, and the NASDAQ share price compliance issue.
111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024
Neutral
PRNewsWire
1 month ago
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that its release of unaudited financial results for the third quarter ended September 30, 2024, previously scheduled for Thursday, November 28, 2024, will now occur before the U.S. market opens on Wednesday, November 27, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Wednesday, November 27, 2024 (8:30 PM Beijing Time on the same day).
111 Reschedules Third Quarter 2024 Unaudited Financial Results Announcement to November 27, 2024 - Conference Call to Follow
Neutral
PRNewsWire
1 month ago
111, Inc. Announces Change to Board of Directors
SHANGHAI , Nov. 4, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that Dr. Leon Lian Yong Chen has tendered his resignation from the position as the Company's director for personal reasons, effective on November 4, 2024. The board has also appointed Mr.
111, Inc. Announces Change to Board of Directors
Neutral
PRNewsWire
1 month ago
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
SHANGHAI , Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research ("WTR") on Wednesday, October 30, 2024 at 12:00 p.m. ET. Dr. Gang Yu, Co-Founder and Executive Chairman of 111, will discuss the Company's logistics network, including an overview of its fulfillment centers, operating models, and technological innovations enhancing procurement and last-mile delivery in addition to the network's plans for expansion.
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
Neutral
PRNewsWire
2 months ago
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
SHANGHAI , Oct. 18, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2024, before the U.S. market opens on Thursday, November 28, 2024. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 28, 2024 (8:30 PM Beijing Time on the same day).
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow
Neutral
PRNewsWire
2 months ago
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
SHANGHAI , Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that new fulfillment centers in South and Central China began operations in Guangzhou, Guangdong Province, and Wuhan, Hubei Province, respectively. These strategic expansions mark a significant step forward in enhancing its national supply chain network, increasing efficiency and speed to better meet growing market demand.
111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
Neutral
PRNewsWire
2 months ago
111, Inc. Announces Receipt of Notification from Nasdaq
SHANGHAI , Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced it has received a notification letter dated September 26, 2024 (the "Notice") from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), indicating that for the last 30 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1).
111, Inc. Announces Receipt of Notification from Nasdaq
Neutral
GlobeNewsWire
3 months ago
Synthetic Fiber Market Size is Anticipated to Reach USD 111.9 billion, Advancing at a CAGR of 4.8% by 2034: Transparency Market Research Inc.
Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles. Surge in demand for synthetic fibers in the medical sector for manufacturing surgical garments, wound dressings, and medical textiles.
Synthetic Fiber Market Size is Anticipated to Reach USD 111.9 billion, Advancing at a CAGR of 4.8% by 2034: Transparency Market Research Inc.
Charts implemented using Lightweight Charts™